{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-001341","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2025-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.088648+00:00","generated_at":"2026-05-28T09:53:47.715124+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CytoSorbents opens regional sales subsidiary in Dubai, UAE","bullets":["New subsidiary in Dubai Science Park will serve as a sales hub for the Middle East and Africa.","Dr. Phillip Chan cites growing regional demand for critical care and cardiac surgery therapies.","Subsidiary aims to strengthen existing partnerships, support customers, and drive sales growth.","Dubai was chosen for its strategic location, strong economy, favorable tax policies, and advanced healthcare infrastructure."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-001341","json":"https://secwatch.observer/filing/0001104659-25-001341.json","markdown":"https://secwatch.observer/filing/0001104659-25-001341.md","text":"https://secwatch.observer/filing/0001104659-25-001341.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465925001341/0001104659-25-001341-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465925001341/tm252036d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T09:53:47.715124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}